This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints, Permissions and Rights Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by POLYCHRONAKOS, C. Articles by POSNER, B. I. Search for Related Content PubMed PubMed Citation Articles by POLYCHRONAKOS, C. Articles by POSNER, B. I.

Increase in the Number of Type II Insulin-Like Growth Factor Receptors during Propylthiouracil-Induced Hyperplasia in the Rat Thyroid^*

Departments of Pediatrics and Medicine, McGill University Montreal, Quebec, Canada H3H 1P3

Address requests for reprints and all correspondence to: Constantin Polychronakos, M.D., Department of Pediatrics, McGill University, Montreal Children's Hospital, 2300 Tupper Street, Montreal, Quebec, Canada H3H 1P3.

Abstract

We have observed that membranes isolated from rat thyroids contain receptors for the insulin-like growth factors (IGF). As IGFs are known to be important mediators of tissue growth, we conducted this study to determine whether modulation of thyroid IGF receptors might be involved in TSH-stimulated hyperplasia.

A substantial increase in both the weight of the thyroid and its DNA content was observed within 2 days of exposing adult male rats to 0.1% propylthiouracil (PTU) in their drinking water. Serum T₄ reached unmeasurable levels and serum TSH rose 3-fold over control by the tenth day of treatment.

[¹²⁵I]Iodo-human(h)IGF-II binding to membranes isolated from hyperplastic glands was significantly higher than control beginning at 2 days. A maximum was reached after 5 days (13.3 ± 0.8%/25 ng protein us. a control level of 6.7 ± 0.7%, mean ± SEM). The increase had disappeared by 15 days of PTU exposure, paralleling the drastic fall in the growth rate of the glands. This increase in binding was specific for the thyroid, as it was not seen in other organs.

In both treated and control animals, the receptor involved was shown to be type II by preferential binding to IGF-II, lack of interaction with insulin, and molecular sizing. The observed increase in binding could be accounted for by an increase in receptor site number, the affinity remaining essentially the same.

We conclude that the TSH-stimulated hyperplasia of the rat thyroid, induced by PTU, is associated with an increase in the binding sites of the type II IGF receptor. This observation raises the possibility that modulation of this receptor may play a role in the mediation of the mitogenic effect of TSH on the thyroid gland. {Endocrinology 119: 1204-1209,1986)

Footnotes

^* Supported by the Medical Research Council of Canada (MA-8614). This is publication No 86016 of the McGill University-Montreal Children's Hospital Research Institute.

Received August 27, 1985.

This article has been cited by other articles:

				B. S. Schaffer, M.-F. Lin, J. C. Byrd, J. H. Y. Park, and R. G. MacDonald Opposing Roles for the Insulin-Like Growth Factor (IGF)-II and Mannose 6-Phosphate (Man-6-P) Binding Activities of the IGF-II/Man-6-P Receptor in the Growth of Prostate Cancer Cells Endocrinology, March 1, 2003; 144(3): 955 - 966. [Abstract] [Full Text] [PDF]

				N. Fujimoto, H. Onodera, K. Mitsumori, T. Tamura, S. Maruyama, and A. Ito Changes in thyroid function during development of thyroid hyperplasia induced by kojic acid in F344 rats Carcinogenesis, August 1, 1999; 20(8): 1567 - 1572. [Abstract] [Full Text] [PDF]